Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease

International Urology and Nephrology

Volumn 44, Issue 2, 2012, Pages 541-547

  Lishmanov, Anton ^a   Dorairajan, Smrita ^a   Pak, Youngju ^a   Chaudhary, Kunal ^a   Chockalingam, Anand ^a  

^a University of Missouri   (United States)

Author keywords

Cardiovascular events; Chronic kidney disease; Hyperparathyroidism

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PARATHYROID HORMONE; PHOSPHATE;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ARTERY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CORONARY ARTERY; CORONARY ARTERY RECANALIZATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; STROKE; VITAMIN BLOOD LEVEL;

EID: 84861863796     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-010-9897-2     Document Type: Article

References (37)

1. Coresh J et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038-2047 (Pubitemid 350074801)
2. Sarnak MJ et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42(5):1050-1065 (Pubitemid 37413751)
3. Daly C (2007) Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK consensus conference on early chronic kidney disease. Nephrol Dial Transplant 22(Suppl 9): ix19-ix25
4. Kimata N et al (2007) Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int 11(3):340-348 (Pubitemid 46958589)
5. Marco MP et al. (2003) Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population. Kidney Int Suppl(85):S111-S114 (Pubitemid 36608935)
6. Young EW et al (2005) Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study. Kidney Int 67(3):1179-1187 (Pubitemid 41623345)
7. Kovesdy CP et al (2008) Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73(11): 1296-1302 (Pubitemid 351693159)
8. De Boer IH et al (2002) The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFRdependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 13(11):2762-2769 (Pubitemid 35216046)
9. Bhuriya R et al (2009) Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the kidney early evaluation program (KEEP). Am J Kidney Dis 53(4 Suppl 4):S3-S10
10. Kamycheva E, Sundsfjord J, Jorde R (2004) Serum parathyroid hormone levels predict coronary heart disease: the Tromso study. Eur J Cardiovasc Prev Rehabil 11(1):69-74 (Pubitemid 38388927)
11. Hagstrom E et al (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21):2765-2771
12. Pilz S, Tomaschitz A, Drechsler C et al (2010) Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 31(13):1591-1598 Epub 2010 May 2
13. Llach F (1995) Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis 25(5):663-679
14. Schumock GT et al (2009) Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract 113(1):c54-c61
15. Jassal SK, Chonchol M, Mühlen DV et al (2010) Vitamin D, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am J Med 123(12):1114-1120
16. Slinin Y, Foley RN, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16:1788-1793 (Pubitemid 41716485)
17. Covic A et al (2009) Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24(5):1506-1523
18. Usdin TB et al (1996) Distribution of parathyroid hormone- 2 receptor messenger ribonucleic acid in rat. Endocrinology 137(10):4285-4297 (Pubitemid 26321877)
19. Smogorzewski M (1995) PTH, chronic renal failure and myocardium. Miner Electrolyte Metab 21(1-3):55-62
20. Ogino K, Burkhoff D, Bilezikian JP (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136(7): 3024-3030
21. Schluter KD, Piper HM (1992) Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 263(6 Pt 2):H1739-H1746 (Pubitemid 23030726)
22. Amann K et al (1994) A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4(10):1814-1819
23. Schleiffer R, Pernot F, Jones R (1995) Endothelium is a target organ of parathyroid secretions in genetic hypertensive rats. Horm Metab Res 27(1):16-18
24. Noda M et al (1997) Increased expression of parathyroid hormone-related peptide gene in blood vessels of spontaneously hypertensive rats. Hypertension 30(5):1284-1288 (Pubitemid 27476192)
25. Ejerblad S, Eriksson I, Johansson H (1979) Uraemic arterial disease. An experimental study with special reference to the effect of parathyroidectomy. Scand J Urol Nephrol 13(2):161-169
26. Neves KR et al (2007) Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 71(12): 1262-1270 (Pubitemid 46884255)
27. Rashid G et al (2007) Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 292(4):F1215-F1218 (Pubitemid 46572440)
28. Perkovic V et al (2003) Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 26(1):27-33 (Pubitemid 36438798)
29. Saleh FN et al (2003) Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24(22):2054-2060 (Pubitemid 37420453)
30. Harnett JD et al (1988) Left ventricular hypertrophy in end-stage renal disease. Nephron 48(2):107-115
31. Piovesan A et al (1999) Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50(3):321-328
32. Hara S et al (1995) Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrolyte Metab 21(1-3):72-76
33. Park CW et al (1999) Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33(1): 73-81
34. Akmal M et al (1985) Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75(3):1037-1044 (Pubitemid 15115274)
35. Fadda GZ et al (1991) On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 87(1):255-261
36. Ogard CG et al (2005) Increased plasma N-terminal pro-Btype natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 63(5):493-498 (Pubitemid 41626742)
37. Delfini E et al (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 56(1):30-36 (Pubitemid 44856740)